Infinium Global Research Biological Drugs Market | Page 4

of stringent regulatory frameworks, presence of biosimilars and other alternatives are the major restraints for African
biological drugs market. However, with the Ebola outbreak in recent past and the presence of large number of patients with
AIDS and other chronic illnesses provide positive outlook for the growth of the biological drugs market in Africa. Presence of
numerous patients with diabetes, rheumatoid arthritis and other chronic illnesses and availability of good healthcare systems
are expected to drive the biological drugs market in the Middle East during the forecast period.
Companies Profiled:
AbbVieInc,
Amgen Inc,
Bristol-Myers Squibb,
Biogen Idec,
Hoffman-La Roche AG,
Johnson & Johnson,
Lilly,
Merck & Co Inc,
Novartis,
Novo Nordisk,
Pfizer Inc,
Sanofi SA.
Infinium Global Research